Position in GSK
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$66,821,071
+$50,067,634 QoQ
Shares Held
1,210,746
+254.4% QoQ
Ownership
0.060%
of shares outstanding
% of Portfolio
0.21%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2024
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GSK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Alyeska Investment Group, L.P. holds $909,020,667 across 5 Drug Manufacturers - General names.
All Filings in GSK
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $66,821,071 | 1,210,746 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $16,753,437 | 341,628 | Shares | Sole | 2026-02-13 | |
| 2025-06-30 | $121,224,000 | 3,156,875 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $67,266,508 | 1,736,358 | Shares | Sole | 2025-05-15 | |
| 2024-03-31 | $891,867 | 20,804 | Shares | Sole | 2024-05-15 | |
| No filing history on record for this holder in this stock. | ||||||